The Role of Surgical Resection in Patients with Brain Metastases

Overview

Journal Ecancermedicalscience

Specialty Oncology

Date 2013 May 2

PMID 23634178

Citations 40

Authors

Mustafa Aziz Hatiboglu

David M Wildrick

Raymond Sawaya

Affiliations

Soon will be listed here.

Abstract

Brain metastasis is a devastating complication of systemic malignancy that affects a considerable number of cancer patients. The appearance of brain metastases is often considered to be a sign of poor prognosis; in patients with brain metastases poor survival time has been reported in the literature. Therefore, treatment of these brain lesions in cancer patients is important for quality of life, providing local tumour control, preventing death from neurological causes, and improving survival, although potentially only in a minority of patients. Surgical resection of brain metastases has been the cornerstone treatment in select patients. Careful patient selection, the use of appropriate surgical techniques, and surgical adjuncts are the major determinants of favourable outcome in patients undergoing resection of brain metastases. In this review, we explain the role of surgical resection in the treatment of patients with brain metastases with consideration of patient selection, surgical techniques and the use of intraoperative adjuncts.

Citing Articles

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

von Arx C, Calderaio C, Calabrese A, Marciano B, Martinelli C, Lauro V Front Oncol. 2025; 14:1447508.

PMID: 39749036 PMC: 11693720. DOI: 10.3389/fonc.2024.1447508.

A prospective study on the usefulness of high-resolution intraoperative infrared thermography in intracranial tumors.

Menezes D, de Lima L, Mansilla R, Conci A, Rueda F, Velarde L Front Surg. 2024; 11:1386722.

PMID: 38933651 PMC: 11199714. DOI: 10.3389/fsurg.2024.1386722.

Defining the role of surgery for patients with multiple brain metastases.

Ersoy T, Brainman D, Coras R, Berger B, Weissinger F, Grote A J Neurooncol. 2024; 169(2):317-328.

PMID: 38916848 PMC: 11341766. DOI: 10.1007/s11060-024-04739-7.

Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy.

Buchner J, Kofler F, Mayinger M, Christ S, Brunner T, Wittig A Neuro Oncol. 2024; 26(9):1638-1650.

PMID: 38813990 PMC: 11376458. DOI: 10.1093/neuonc/noae098.

References

Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72. DOI: 10.1016/S0140-6736(04)16250-8. View

Senft C, Ulrich C, Seifert V, Gasser T . Intraoperative magnetic resonance imaging in the surgical treatment of cerebral metastases. J Surg Oncol. 2010; 101(5):436-41. DOI: 10.1002/jso.21508. View

Mintz A, Kestle J, Rathbone M, Gaspar L, Hugenholtz H, Fisher B . A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996; 78(7):1470-6. DOI: 10.1002/(sici)1097-0142(19961001)78:7<1470::aid-cncr14>3.0.co;2-x. View

Brega K, Robinson W, Winston K, Wittenberg W . Surgical treatment of brain metastases in malignant melanoma. Cancer. 1990; 66(10):2105-10. DOI: 10.1002/1097-0142(19901115)66:10<2105::aid-cncr2820661011>3.0.co;2-i. View

Horton J, BAXTER D, OLSON K . The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med. 1971; 111(2):334-6. DOI: 10.2214/ajr.111.2.334. View

Murray K, Scott C, Greenberg H, Emami B, Seider M, Vora N . A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997; 39(3):571-4. DOI: 10.1016/s0360-3016(97)00341-6. View

Shinoura N, Yamada R, Okamoto K, Nakamura O, Shitara N . Local recurrence of metastatic brain tumor after stereotactic radiosurgery or surgery plus radiation. J Neurooncol. 2002; 60(1):71-7. DOI: 10.1023/a:1020256721761. View

Galicich J, Sundaresan N, Arbit E, Passe S . Surgical treatment of single brain metastasis: factors associated with survival. Cancer. 1980; 45(2):381-6. DOI: 10.1002/1097-0142(19800115)45:2<381::aid-cncr2820450232>3.0.co;2-j. View

Skibber J, Soong S, Austin L, Balch C, Sawaya R . Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol. 1996; 3(2):118-23. DOI: 10.1007/BF02305789. View

10.

Markesbery W, Brooks W, Gupta G, Young A . Treatment for patients with cerebral metastases. Arch Neurol. 1978; 35(11):754-6. DOI: 10.1001/archneur.1978.00500350058012. View

11.

Salvati M, Capoccia G, Orlando E, Fiorenza F, Gagliardi F . Single brain metastases from breast cancer: remarks on clinical pattern and treatment. Tumori. 1992; 78(2):115-7. DOI: 10.1177/030089169207800210. View

12.

Tan T, Black P . Image-guided craniotomy for cerebral metastases: techniques and outcomes. Neurosurgery. 2003; 53(1):82-9; discussion 89-90. DOI: 10.1227/01.neu.0000068729.37362.f9. View

13.

Patel A, Suki D, Hatiboglu M, AbouAssi H, Shi W, Wildrick D . Factors influencing the risk of local recurrence after resection of a single brain metastasis. J Neurosurg. 2009; 113(2):181-9. DOI: 10.3171/2009.11.JNS09659. View

14.

Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K . Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Int J Radiat Oncol Biol Phys. 2000; 46(2):297-302. DOI: 10.1016/s0360-3016(99)00416-2. View

15.

Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R . A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322(8):494-500. DOI: 10.1056/NEJM199002223220802. View

16.

Lagerwaard F, Levendag P, Nowak P, Eijkenboom W, Hanssens P, Schmitz P . Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43(4):795-803. DOI: 10.1016/s0360-3016(98)00442-8. View

17.

Baumert B, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx M, Debougnoux-Huppertz R . A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys. 2006; 66(1):187-94. DOI: 10.1016/j.ijrobp.2006.03.050. View

18.

Kelly K, Bunn Jr P . Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?. Lung Cancer. 1998; 20(2):85-91. DOI: 10.1016/s0169-5002(98)00020-8. View

19.

Thomas A, Rock J, Johnson C, WEISS L, Jacobsen G, Rosenblum M . Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan. J Neurosurg. 2000; 93(6):927-31. DOI: 10.3171/jns.2000.93.6.0927. View

20.

Stark A, Tscheslog H, Buhl R, Held-Feindt J, Mehdorn H . Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev. 2004; 28(2):115-9. DOI: 10.1007/s10143-004-0364-3. View